Drug Information for CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP): INDICATIONS AND USAGE

Ads
  • CASODEX 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analogue for the treatment of Stage D2 metastatic carcinoma of the prostate.

    CASODEX 150 mg daily is not approved for use alone or with other treatments. See CLINICAL PHARMACOLOGY-Clinical Studies- Safety Data from Clinical Studies using CASODEX 150 mg section for additional important safety information regarding CASODEX 150 mg.

  • Drug Information Provided by National Library of Medicine (NLM).
Ads